OpenAlex
PricingAboutJobs
Log inGet started
Work

Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?

HTML PDF

Year: 2025
Type: editorial
Source: The AAPS Journal
DOI: 10.1208/s12248-025-01135-5
Authors: Yan G. Ni, Lauren F. Stevenson, Lakshmi Amaravadi, Carmen Fernández-Metzler, Lindsay King, Steven P. Piccoli, Amanda Hays, Dhiman Ghosh, Sarah Mitchell Bean, Stephanie Cape, Enrique A. Dalmasso, Shashank Gorityala, Jennifer Green, Michele Gunsior, Mohamed Hassanein, Sreenivas Laxmanan, Robert J. Neely, Alok Pandey, Xiazi Qiu, Chunyan Tinder, Jianing Zeng, Jad Zoghbi, Karen J. Quadrini
Institutions: Pfizer (United States), Wave Life Sciences (United States), Charles River Laboratories (United States), LabCorp (United States), United States Pharmacopeial Convention, PBL Assay Science (United States), Moderna Therapeutics (United States), Biogen (United States), Prothena (United States)
Language: English

Topic: Biosimilars and Bioanalytical Methods
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W4414652281
Cites: 13
Cited by: 6
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms